Abstract
Among beneficial applications of nanotechnology, nanomedicine offers perhaps the greatest potential for improving human conditions and quality of life. Engineered nanomaterials (ENMs), with their unique properties, have potential to improve therapy of many human disorders. The properties that make ENMs so useful could also lead to unintentional adverse health effects. Challenges arising from physicochemical properties of ENMs, their characterization, exposure, and hazard assessment and other key issues of ENM safety are discussed. There is still scant knowledge about ENM cellular uptake, transport across biological barriers, distribution within the body, and possible mechanisms of toxicity. The safety of ENMs should be tested to minimize possible risk before the application. However, existing toxicity tests need to be adapted to fit to the unique features related to the nanosized material and appropriate controls and reference material should be considered.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Donaldson K, Stone V, Tran CL et al (2004) Nanotoxicology. Occup Environ Med 61:727–728
Haynes CL (2010) The emerging field of nanotoxicology. Anal Bioanal Chem 398:587–588
Maynard AD, Warheit DB, Philbert MA (2011) The new toxicology of sophisticated materials: nanotoxicology and beyond. Toxicol Sci 120(Suppl 1):S109–S129
Kroll A, Pillukat MH, Hahn D et al (2009) Current in vitro methods in nanoparticle risk assessment: limitations and challenges. Eur J Pharm Biopharm 72:370–377
Feliu N, Fadeel B (2010) Nanotoxicology: no small matter. Nanoscale 2:2514–2520
Dusinska M, Fjellsbo L, Magdolenova Z et al (2009) Testing strategies for the safety of nanoparticles used in medical applications. Nanomedicine (Lond) 4:605–607
EMEA (2006) Reflection Paper on Nanotechnology-Based Medicinal Products for Human Use, EMEA/CHMP/79769/2006. www.emea.europa.eu/pdfs/human/genetherapy/7976906en.pdf
Gwinn MR, Tran L (2010) Risk management of nanomaterials. Wiley Interdiscip Rev Nanomed Nanobiotechnol 2:130–137
Stone V, Nowack B, Baun A et al (2010) Nanomaterials for environmental studies: classification, reference material issues, and strategies for physico-chemical characterization. Sci Total Environ 408:1745–17454
Bouwmeester H, Lynch I, Marvin HJP et al (2011) Minimal analytical characterisation of engineered nanomaterials needed for hazard assessment in biological matrices. Nanotoxicology 5:1–11
Commitee ES (2011) Guidance on the risk assessment of the application of nanoscience and nanotechnologies in the food and feed chain. EFSA Journal 9:2140–2176
Faraji AH, Wipf P (2009) Nanoparticles in cellular drug delivery. Bioorg Med Chem 17:2950–2962
Warheit DB, Sayes CM, Reed KL et al (2008) Health effects related to nanoparticle exposures: environmental, health and safety considerations for assessing hazards and risks. Pharmacol Ther 120:35–42
Kunzmann A, Andersson B, Thurnherr T et al (2011) Toxicology of engineered nanomaterials: focus on biocompatibility, biodistribution and biodegradation. Biochim Biophys Acta 1810:361–373
Dhawan A, Sharma V (2010) Toxicity assessment of nanomaterials: methods and challenges. Anal Bioanal Chem 398:589–605
Borm PJ, Muller-Schulte D (2006) Nanoparticles in drug delivery and environmental exposure: same size, same risks? Nanomedicine (Lond) 1:235–249
Oberdorster G, Oberdorster E, Oberdorster J (2005) Nanotoxicology: an emerging discipline evolving from studies of ultrafine particles. Environ Health Perspect 113:823–839
Adiseshaiah PP, Hall JB, McNeil SE (2009) Nanomaterial standards for efficacy and toxicity assessment. Nanotechnology 2:99–112
Goodman CM, McCusker CD, Yilmaz T et al (2004) Toxicity of gold nanoparticles functionalized with cationic and anionic side chains. Bioconjug Chem 15:897–900
Kayat J, Gajbhiye V, Tekade RK et al (2011) Pulmonary toxicity of carbon nanotubes: a systematic report. Nanomedicine 7:40–49
Nel A (2005) Atmosphere air pollution-related illness: effects of particles. Science 308:804
Eom HJ, Choi J (2010) p38 MAPK activation, DNA damage, cell cycle arrest and apoptosis as mechanisms of toxicity of silver nanoparticles in Jurkat T cells. Environ Sci Technol 44:8337–8342
Hsin YH, Chen CF, Huang S et al (2008) The apoptotic effect of nanosilver is mediated by a ROS- and JNK-dependent mechanism involving the mitochondrial pathway in NIH3T3 cells. Toxicol Lett 179:130–139
Dailey LA, Jekel N, Fink L et al (2006) Investigation of proinflammatory potential of biodegradable nanoparticle drug delivery systems in the lung. Toxicol Appl Pharmacol 215:100–108
Magdolenova Z, Dhawan A, Collins A, Stone V, Dusinska M Mechanisms of Genotoxicity. A Review of Recent in vitro and in vivo Studies with Engineered Nanoparticles. Nanotoxicology. Submitted
Stone V, Johnston H, Schins RP (2009) Development of in vitro systems for nanotoxicology: methodological considerations. Crit Rev Toxicol 39:613–626
Singh N, Manshian B, Jenkins GJ et al (2009) NanoGenotoxicology: the DNA damaging potential of engineered nanomaterials. Biomaterials 30:3891–3914
Liang XJ, Chen C, Zhao Y et al (2008) Biopharmaceutics and therapeutic potential of engineered nanomaterials. Curr Drug Metab 9:697–709
Asharani PV, Low Kah Mun G, Hande MP et al (2009) Cytotoxicity and genotoxicity of silver nanoparticles in human cells. ACS Nano 3:279–290
Seaton A, Tran L, Aitken R et al (2010) Nanoparticles, human health hazard and regulation. J R Soc Interface 7(Suppl 1):S119–S129
Simko M, Mattsson MO (2010) Risks from accidental exposures to engineered nanoparticles and neurological health effects: a critical review. Part Fibre Toxicol 7:42
Oberdörster G, Maynard A, Donaldson K et al (2005) Principles for characterizing the potential human health effects from exposure to nanomaterials: elements of a screening strategy. Part Fibre Toxicol 2:8
Abbott A (2003) Cell culture: biology’s new dimension. Nature 424:870–872
Byrne H. J., Lynch I., de Jong W. H. et al. (2010) Protocols for assessment of biological hazards of engineered nanoparticles. European network on the health and environmental impact of nanomaterials, pp 1–30, http://www.nanoimpactnet.eu/uploads/file/Reports_Publications/D1.7%20Protocols%20for%20Assessment%20Bio-Hazards%20in%20ENMs.pdf
Priya BR, Byrne HJ (2008) Investigation of sodium dodecyl benzene sulphonate assisted dispersion and debundling of single wall carbon nanotubes. J Phys Chem C 112:332–337
Liu F, Soares MJ, Audus KL (1997) Permeability properties of monolayers of the human trophoblast cell line BeWo. Am J Physiol 273:C1596–C1604
Ampasavate C, Chandorkar GA, Vande Velde DG et al (2002) Transport and metabolism of opioid peptides across BeWo cells, an in vitro model of the placental barrier. Int J Pharm 233:85–98
Saunders M (2009) Transplacental transport of nanomaterials. Wiley Interdiscip Rev Nanomed Nanobiotechnol 1:671–684
Brown J, Reading SJ, Jones S et al (2000) Critical evaluation of ECV304 as a human endothelial cell model defined by genetic analysis and functional responses: a comparison with the human bladder cancer derived epithelial cell line T24/83. Lab Invest 80:37–45
Saovapakhiran A, D’Emanuele A, Attwood D et al (2009) Surface modification of PAMAM dendrimers modulates the mechanism of cellular internalization. Bioconjug Chem 20:693–701
Herzog E, Casey A, Lyng FM et al (2007) A new approach to the toxicity testing of carbon-based nanomaterials-the clonogenic assay. Toxicol Lett 174:49–60
Ng CT, Li JJ, Bay BH et al (2010) Current studies into the genotoxic effects of nanomaterials. J Nucleic Acids pii:947859
Mortelmans K, Zeiger E (2000) The Ames Salmonella/microsome mutagenicity assay. Mutat Res 455:29–60
Landsiedel R, Kapp MD, Schulz M et al (2009) Genotoxicity investigations on nanomaterials: methods, preparation and characterization of test material, potential artifacts and limitations-many questions, some answers. Mutat Res 681:241–258
Shinohara N, Matsumoto K, Endoh S et al (2009) In vitro and in vivo genotoxicity tests on fullerene C60 nanoparticles. Toxicol Lett 191:289–296
Mori T, Takada H, Ito S et al (2006) Preclinical studies on safety of fullerene upon acute oral administration and evaluation for no mutagenesis. Toxicology 225:48–54
Wirnitzer U, Herbold B, Voetz M et al (2009) Studies on the in vitro genotoxicity of baytubes, agglomerates of engineered multi-walled carbon-nanotubes (MWCNT). Toxicol Lett 186:160–165
Di Sotto A, Chiaretti M, Carru GA et al (2009) Multi-walled carbon nanotubes: lack of mutagenic activity in the bacterial reverse mutation assay. Toxicol Lett 184:192–197
Balasubramanyam A, Sailaja N, Mahboob M et al (2010) In vitro mutagenicity assessment of aluminium oxide nanomaterials using the Salmonella/microsome assay. Toxicol In Vitro 24:1871–1876
Maenosono S, Suzuki T, Saita S (2007) Mutagenicity of water-soluble FePt nanoparticles in Ames test. J Toxicol Sci 32:575–579
Maenosono S, Yoshida R, Saita S (2009) Evaluation of genotoxicity of amine-terminated water-dispersible FePt nanoparticles in the Ames test and in vitro chromosomal aberration test. J Toxicol Sci 34:349–354
Yoshida R, Kitamura D, Maenosono S (2009) Mutagenicity of water-soluble ZnO nanoparticles in Ames test. J Toxicol Sci 34:119–122
Collins AR, Dusinska M, Gedik CM et al (1996) Oxidative damage to DNA: do we have a reliable biomarker? Environ Health Perspect 104(Suppl 3):465–469
Dusinska M, Collins AR (1996) Detection of oxidised purines and UV-induced photoproducts in DNA, by inclusion of lesion-specific enzymes in the comet assay (single cell gel electrophoresis). ATLA 24:405–411
Jha AN (2008) Ecotoxicological applications and significance of the comet assay. Mutagenesis 23:207–221
O.E.C.D. (1997) Guidelines for testing chemicals. Mammalian erythrocyte micronucleus test. Vol. Guideline 474, Adopted: 21st July 1997, pp 1–10, http://www.oecd.org/chemicalsafety/assessmentofchemicals/1948442.pdf
Fenech M (2007) Cytokinesis-block micronucleus cytome assay. Nat Protoc 2:1084–1104
Laingam S, Froscio SM, Humpage AR (2008) Flow-cytometric analysis of in vitro micronucleus formation: comparative studies with WIL2-NS human lymphoblastoid and L5178Y mouse lymphoma cell lines. Mutat Res 656:19–26
Fenech M, Kirsch-Volders M, Natarajan AT et al (2011) Molecular mechanisms of micronucleus, nucleoplasmic bridge and nuclear bud formation in mammalian and human cells. Mutagenesis 26:125–132
Gonzalez L, Sanderson BJ, Kirsch-Volders M (2011) Adaptations of the in vitro MN assay for the genotoxicity assessment of nanomaterials. Mutagenesis 26:185–191
Doak SH, Griffiths SM, Manshian B et al (2009) Confounding experimental considerations in nanogenotoxicology. Mutagenesis 24:285–293
Hackenberg S, Scherzed A, Kessler M et al (2011) Silver nanoparticles: evaluation of DNA damage, toxicity and functional impairment in human mesenchymal stem cells. Toxicol Lett 201:27–33
Galloway SM, Aardema MJ, Ishidate M Jr et al (1994) Report from working group on in vitro tests for chromosomal aberrations. Mutat Res 312:241–261
Galloway SM, Armstrong MJ, Reuben C et al (1987) Chromosome aberrations and sister chromatid exchanges in Chinese hamster ovary cells: evaluations of 108 chemicals. Environ Mol Mutagen 10(Suppl 10):1–175
Benigni R, Bossa C (2011) Alternative strategies for carcinogenicity assessment: an efficient and simplified approach based on in vitro mutagenicity and cell transformation assays. Mutagenesis 26:455–460
Clift MJ, Gehr P, Rothen-Rutishauser B (2011) Nanotoxicology: a perspective and discussion of whether or not in vitro testing is a valid alternative. Arch Toxicol 85:723–731
Fischer HC, Chan WC (2007) Nanotoxicity: the growing need for in vivo study. Curr Opin Biotechnol 18:565–571
Acknowledgment
Supported by European Commission Seventh Framework Programme [Health-2007-1.3-4], Contract no: 201335, www.nanotest-fp7.eu
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2013 Springer Science+Business Media, LLC
About this protocol
Cite this protocol
Dusinska, M., Magdolenova, Z., Fjellsbø, L.M. (2013). Toxicological Aspects for Nanomaterial in Humans. In: Ogris, M., Oupicky, D. (eds) Nanotechnology for Nucleic Acid Delivery. Methods in Molecular Biology, vol 948. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-62703-140-0_1
Download citation
DOI: https://doi.org/10.1007/978-1-62703-140-0_1
Published:
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-1-62703-139-4
Online ISBN: 978-1-62703-140-0
eBook Packages: Springer Protocols